ID   YCCEL1
AC   CVCL_9647
AS   CVCL_L440
SY   YCC-10; YCC10
DR   EFO; EFO_0002877
DR   cancercelllines; CVCL_9647
DR   GEO; GSM552379
DR   GEO; GSM562399
DR   Progenetix; CVCL_9647
DR   Wikidata; Q54995318
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=18804159;
RX   PubMed=23175241;
RX   PubMed=25787276;
RX   PubMed=26889033;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Virology: Contains a complete EBV genome (strain YCCEL1) which has been sequenced (PubMed=25787276; PubMed=26889033).
CC   Doubling time: 50 hours (PubMed=29435981).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.His58Leu; Zygosity=Unspecified (PubMed=29435981).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
RX   DOI=10.1158/1538-7445.AM2016-139;
RA   Kim T.S., Park K.H., Kwon W.S., Lee W.S., Jeong I., Kang S.K.,
RA   Kim H.M., Rha S.Y., Chung H.C.;
RT   "Novel gastric cancer cell lines established from diffuse type gastric
RT   cancer patients for potential subgroup-specific therapy.";
RL   Cancer Res. 76 Suppl. 14:139-139(2016).
//
RX   PubMed=18804159; DOI=10.1016/j.ygeno.2008.08.002;
RA   Jung J.-J., Jeung H.-C., Chung H.C., Lee J.O., Kim T.S., Kim Y.T.,
RA   Noh S.H., Rha S.Y.;
RT   "In vitro pharmacogenomic database and chemosensitivity predictive
RT   genes in gastric cancer.";
RL   Genomics 93:52-61(2009).
//
RX   PubMed=23175241; DOI=10.1099/vir.0.045237-0;
RA   Kim D.N., Seo M.K., Choi H., Kim S.Y., Shin H.J., Yoon A.-R., Tao Q.,
RA   Rha S.Y., Lee S.K.;
RT   "Characterization of naturally Epstein-Barr virus-infected gastric
RT   carcinoma cell line YCCEL1.";
RL   J. Gen. Virol. 94:497-506(2013).
//
RX   PubMed=25787276; DOI=10.1128/JVI.03614-14; PMCID=PMC4442510;
RA   Palser A.L., Grayson N.E., White R.E., Corton C., Correia S.,
RA   Ba Abdullah M.M., Watson S.J., Cotten M., Arrand J.R., Murray P.G.,
RA   Allday M.J., Rickinson A.B., Young L.S., Farrell P.J., Kellam P.;
RT   "Genome diversity of Epstein-Barr virus from multiple tumor types and
RT   normal infection.";
RL   J. Virol. 89:5222-5237(2015).
//
RX   PubMed=26889033; DOI=10.1128/JVI.00060-16; PMCID=PMC4836357;
RA   Kanda T., Furuse Y., Oshitani H., Kiyono T.;
RT   "Highly efficient CRISPR/Cas9-mediated cloning and functional
RT   characterization of gastric cancer-derived Epstein-Barr virus
RT   strains.";
RL   J. Virol. 90:4383-4393(2016).
//
RX   PubMed=29435981; DOI=10.1002/ijc.31304;
RA   Kim H.J., Kang S.K., Kwon W.S., Kim T.S., Jeong I., Jeung H.-C.,
RA   Kragh M., Horak I.D., Chung H.C., Rha S.Y.;
RT   "Forty-nine gastric cancer cell lines with integrative genomic
RT   profiling for development of c-MET inhibitor.";
RL   Int. J. Cancer 143:151-159(2018).
//